Avatrombopag-d8 hydrochloride

SL-7912

Avatrombopag-d₈ hydrochloride, >98%

Synonyms : AKR-501-d₈ hydrochloride; E5501-d₈ hydrochloride; YM477-d₈ hydrochloride

IUPAC Name : 1-(3-Chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl-d₈)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid hydrochloride

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Avatrombopag hydrochloride, which is an orally administered, small-molecule thrombopoietin receptor (c-Mpl) agonist which increases platelet number, but not platelet activation. Avatrombopag may help treat low blood platelet count in adults with immune thrombocytopenia (ITP) and chronic liver disease (CLD).

References : Fukushima-Shintani M. et al.: Eur. J. Haematol., 82(4), 247-254, 2009; Xu H. et al.: Expert Rev Clin Pharmacol., 12(9), 859-865, 2019; Nomoto M. et al.: Br. J. Clin Pharmacol., 84(5), 952-960, 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.